Cargando…
Clinical value of soluble urokinase type plasminogen activator receptors in chronic kidney disease
Chronic kidney disease (CKD) will progress to end stage without treatment, the decline off renal function may not linear. A sensitive marker such as soluble urokinase-type plasminogen activator receptors (suPARs) may allow potential intervention and treatment in earlier stages of CKD. OBJECTIVES: Th...
Autores principales: | Ahmed, Reem M., Khalil, Mona A., Ibrahim, Amal H., Eid, Hanaa M., Abdelbasset, Walid Kamal, Soliman, Gaber S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756685/ https://www.ncbi.nlm.nih.gov/pubmed/31567954 http://dx.doi.org/10.1097/MD.0000000000017146 |
Ejemplares similares
-
Detection of soluble urokinase type plasminogen activator receptors in children with gingivitis and normal subjects
por: El‑Patal, Mohamed Abd‑Ellatif, et al.
Publicado: (2022) -
Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017) -
The prognostic value of ephrin type-A2 receptor and Ki-67 in renal cell carcinoma patients: An Immunohistochemical and Bioinformatical Approach; A STROBE - compliant article
por: Talaat, Iman Mamdouh, et al.
Publicado: (2020) -
The value of RPS15 and MRPS27 in ischemic stroke
por: Zhao, Man, et al.
Publicado: (2023) -
The prognostic value of tumor-associated macrophages in glioma patients
por: Shen, Yang, et al.
Publicado: (2023)